BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 695432)

  • 1. [Steroid balance in patients with breast hyperplasia].
    Samundzhan EM; Gorevaia AN; Kartavova NS; Makarchuk NM; Nekrasov PIa
    Vopr Onkol; 1978; 24(8):83-7. PubMed ID: 695432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Steroid balance in breast cancers of varying histological structure].
    Samundzhan EM; Gorevaia AN; Kartavova NS; Nekrasov PIa
    Vopr Onkol; 1980; 26(9):37-41. PubMed ID: 6252695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Quantitative morphological characteristics of the changes in the effector component of the immune system in dyshormonal hyperplasias and breast cancer].
    Abrakova EL
    Vopr Onkol; 1982; 28(10):81-5. PubMed ID: 7147824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Examination of the luteotropic hormone activity of blood and urinary steroid excretion in diseases of the breast].
    Márton Z; Gáti I; Doszpod J; Preisz J; Kecskés L
    Arch Geschwulstforsch; 1969; 34(2):179-87. PubMed ID: 5407886
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hormonal function of the ovaries in women with breast hyperplasia].
    Arsen'eva MG; Savchenko ON; Stepanov GS; Ryzhova RK
    Vopr Onkol; 1976; 22(3):13-9. PubMed ID: 936522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relation of urinary excretion of cholesterol in cancer patients to certain hormonal-metabolic parameters and the effect of drugs on this relation].
    Bershteĭn LM; Tsyrlina EV; Semiglazov VF; Valdina EA; L'vovich EG
    Vopr Med Khim; 1979; 25(2):144-8. PubMed ID: 220799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Urinary estrogen excretion in preneoplastic breast diseases].
    Kozhnazarova IuS; Mezinova NN; Remizova MG; Ikhsanova ST
    Vopr Onkol; 1972; 18(10):23-6. PubMed ID: 4662530
    [No Abstract]   [Full Text] [Related]  

  • 8. [Criteria of radical sector resection in mastopathy].
    Sidorenko LN; Sokolovskiĭ RM
    Vestn Khir Im I I Grek; 1978 Feb; 120(2):79-84. PubMed ID: 644790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Content of 17 beta éstradiol, progesterone and glucocorticoid receptors in patients with benign breast diseases].
    Bassalyk LS; Kuz'mina ZV; Murav'eva NI; Smirnova KD; Vishniakova VV
    Vopr Onkol; 1982; 28(7):3-6. PubMed ID: 7101825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hormonal correlations in hyperplasia of the breasts in women with ovulatory cycles].
    Mezinova NN; Iskakova KI; Bogdanova AG; Kozhnazarova IuS
    Vopr Onkol; 1975; 21(4):12-5. PubMed ID: 1198982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The excretion of pituitary gonadotrophins, oestrogens, pregnanediol and neutral 17-ketosteroids in the urine of patients with metastatic and recurrent mammary carcinoma.
    BROWN JB; BRUCE J; DOUGLAS M; KLOPPER A; LORAINE JA; STRONG JA
    Acta Endocrinol Suppl (Copenh); 1957; 24(Suppl 31):273-4. PubMed ID: 13443787
    [No Abstract]   [Full Text] [Related]  

  • 12. [Excretion of cyclic adenosine monophosphate in breast and lung cancer].
    Bershteĭn LM; Semiglazov VF; Baldina EA
    Vopr Onkol; 1976; 22(8):30-5. PubMed ID: 186954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment urinary hormone patterns and survival in patients with breast cancer, prostate cancer, or lung cancer.
    Marmorston J; Geller PJ; Weiner JM
    Ann N Y Acad Sci; 1969 Oct; 164(2):483-93. PubMed ID: 5260541
    [No Abstract]   [Full Text] [Related]  

  • 14. [Dyshormonal hyperplasia of the mammary gland lobules (mazoplasia) and its results].
    Bystrova VV
    Arkh Patol; 1967; 29(3):12-7. PubMed ID: 5613472
    [No Abstract]   [Full Text] [Related]  

  • 15. [Juvenile fibroadenomatosis associated with mastopathy and macromastia. Clinicopathologic and puncture biopsy cytologic relationships].
    Degrell I
    Pathologe; 1982 Mar; 3(2):85-9. PubMed ID: 7201138
    [No Abstract]   [Full Text] [Related]  

  • 16. [Characteristics in the correlation of ovarian cycle hormones in mastopathy and breast cancer].
    Kuz'mina ZV; Shapoukhova KS; Murav'eva NI; Goncharova MG; Molodyk AA
    Vestn Akad Med Nauk SSSR; 1979; (2):60-4. PubMed ID: 419869
    [No Abstract]   [Full Text] [Related]  

  • 17. [Aneuploidy in focal adenomatosis as a risk factor for the development of breast cancer].
    Neĭshtadt EL; Shalumovich VN; Berezkin DP
    Vopr Onkol; 1976; 22(1):13-6. PubMed ID: 1266115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glucuronic acid, glucuronyltransferase and estrogens in breast cancer and precancer].
    Al'pert AE; Zhandarova LF
    Vopr Onkol; 1978; 24(10):66-70. PubMed ID: 213895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on stromal component of mastopathy--content and type of collagen].
    Okano F
    Hokkaido Igaku Zasshi; 1985 Jul; 60(4):555-70. PubMed ID: 2997011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary phytoestrogen excretion and breast cancer risk: evaluating potential effect modifiers endogenous estrogens and anthropometrics.
    Dai Q; Franke AA; Yu H; Shu XO; Jin F; Hebert JR; Custer LJ; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):497-502. PubMed ID: 12814993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.